Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
00:00
The Signal of a Robust Financing Environment for Biotech
John Defterios: What should people be looking for to tell them that things really are on the uptick? He says it's unlikely that war in Ukraine is going to change anytime soon, inflation is still a challenge. Some M&A coming out of next week's events would be "a real robust signal," he says. And then I think the other thing to look for and maybe it's because people don't like talking about some of the cost containment exercises that were undertaken last year,.
Play episode from 43:07
Transcript
